UNSPSC 51172122: Denaverine or denaverine hydrochloride

This classification denotes an anticholinergic agent with the molecular formulas C24H33NO3 and C24H33NO3.ClH, preparations that US FDA regulates as active ingredients or moieties under Unique Ingredient Identifiers O14NF38MTL and 2AFK8FCD4R. European Medicines Agency schedules Denaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06973MIG.

UNSPSC 51172122 Denaverine or denaverine hydrochloride is a Commodity code that in recent state and local procurement activity does not reflect purchases of the named pharmaceutical product. The single recent opportunity tagged to this code—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—solicits laboratory testing infrastructure, staffing, and analytical services (immunoassay screening with LC/MS/MS or GC/MS confirmation, oral fluid and hair testing, and electronic result reporting) rather than denaverine or any other single active pharmaceutical ingredient. The scope encompasses operation of two collection sites in Plano and McKinney, management of randomized testing notifications via Interactive Voice Response system, and processing approximately 25,031 tests annually across five-panel and six-panel drug screens with confirmation protocols. The successful vendor must hold lab certification from SAMHSA, Texas DPS, or CAP and deliver results electronically with no surcharges beyond stated per-test pricing. This represents a significant mismatch between the code's nominal scope and the work actually being purchased.

The recent activity is confined to Texas, specifically Collin County's criminal justice system. Collin County Community Supervision and Corrections Department issued RFP 2026-327 with an estimated contract value of $600,000 and a two-year initial term commencing September 1, 2026, with three optional one-year renewals. The response date listed in the source (July 23, 2026) appears internally inconsistent with the posting date of September 25, 2026, suggesting a data error. Pricing is per-test across three service models, and proposals are scored on vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), and optional demonstrations and interviews (up to 30 points). No other state or local opportunities under this code appear in the recent data, indicating minimal current procurement activity aligned with the denaverine pharmaceutical classification.